Cargando…
Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs
OBJECTIVE: To validate a mathematical algorithm that calculates risk of diabetic retinopathy progression in a diabetic population with UK staging (R0–3; M1) of diabetic retinopathy. To establish the utility of the algorithm to reduce screening frequency in this cohort, while maintaining safety stand...
Autores principales: | Lund, S H, Aspelund, T, Kirby, P, Russell, G, Einarsson, S, Palsson, O, Stefánsson, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853547/ https://www.ncbi.nlm.nih.gov/pubmed/26377413 http://dx.doi.org/10.1136/bjophthalmol-2015-307341 |
Ejemplares similares
-
Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening
por: Broadbent, Deborah M, et al.
Publicado: (2019) -
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
por: Eleuteri, Antonio, et al.
Publicado: (2017) -
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT
por: Broadbent, Deborah M., et al.
Publicado: (2020) -
Oral health indices predict individualised recall interval
por: Haukka, Anna, et al.
Publicado: (2020) -
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial
por: van Tilborg, Theodora C, et al.
Publicado: (2012)